Brinker Capital Investments’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-16,001
| Closed | -$531K | – | 1684 |
|
|
2022
Q4 | $531K | Sell |
16,001
-16,224
| -50% | -$539K | 0.01% | 956 |
|
|
2022
Q3 | $1.02M | Sell |
32,225
-4,757
| -13% | -$150K | 0.02% | 704 |
|
|
2022
Q2 | $1.13M | Sell |
36,982
-8,272
| -18% | -$252K | 0.02% | 692 |
|
|
2022
Q1 | $1.18M | Buy |
45,254
+1,376
| +3% | +$35.7K | 0.02% | 739 |
|
|
2021
Q4 | $895K | Sell |
43,878
-9,754
| -18% | -$199K | 0.01% | 858 |
|
|
2021
Q3 | $1.19M | Hold |
53,632
| – | – | 0.02% | 714 |
|
|
2021
Q2 | $1.19M | Sell |
53,632
-11,039
| -17% | -$245K | 0.02% | 765 |
|
|
2021
Q1 | $1.7M | Buy |
64,671
+50,359
| +352% | +$1.32M | 0.03% | 559 |
|
|
2020
Q4 | $267K | Sell |
14,312
-34,960
| -71% | -$652K | ﹤0.01% | 949 |
|
|
2020
Q3 | $837K | Buy |
+49,272
| New | +$837K | 0.01% | 740 |
|